Advertisement
Screener

Beyond Air, Inc. (XAIR) Interest and Dividend Income, Operating

2.3 / 5 stars · 23/49 Roast Me

Beyond Air, Inc. Interest and Dividend Income, Operating

Beyond Air, Inc. (XAIR) reported Interest and Dividend Income, Operating of $103.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:InterestAndDividendIncomeOperating · last filed 2026-08-13

  • Beyond Air, Inc. interest and dividend income, operating for the quarter ending 2026-06-30 was $103.00K, a 267.86% increase year-over-year.
  • Beyond Air, Inc. interest and dividend income, operating for the quarter ending 2026-03-31 was $114.00K, a 67.65% increase year-over-year.
  • Beyond Air, Inc. interest and dividend income, operating for the quarter ending 2025-12-31 was $102.00K, a 19.05% decline year-over-year.
  • Beyond Air, Inc. interest and dividend income, operating for the quarter ending 2025-09-30 was $59.00K, a 60.67% decline year-over-year.
  • Beyond Air, Inc. interest and dividend income, operating for fiscal 2026 was $303.00K, a 57.02% decline from fiscal 2025.
  • Beyond Air, Inc. interest and dividend income, operating for fiscal 2025 was $705.00K.
Period endInterest and Dividend Income, Operating 3 monthInterest and Dividend Income, Operating 6 monthInterest and Dividend Income, Operating 9 monthInterest and Dividend Income, Operating 12 month
2026-06-30$103.00K
10-Q · filed 2026-08-13
$217.00K
derived: sum of 2 quarters · filed 2026-08-13
$319.00K
derived: sum of 3 quarters · filed 2026-08-13
$378.00K
derived: sum of 4 quarters · filed 2026-08-13
2026-03-31$114.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-26
$216.00K
derived: sum of 2 quarters · filed 2026-06-26
$275.00K
derived: sum of 3 quarters · filed 2026-06-26
$303.00K
10-K · filed 2026-06-26
2025-12-31$102.00K
10-Q · filed 2026-02-13
$161.00K
derived: sum of 2 quarters · filed 2026-02-13
$189.00K
10-Q · filed 2026-02-13
$257.00K
derived: sum of 4 quarters · filed 2026-08-13
2025-09-30$59.00K
10-Q · filed 2025-11-10
$87.00K
10-Q · filed 2025-11-10
$155.00K
derived: sum of 3 quarters · filed 2026-08-13
$281.00K
derived: sum of 4 quarters · filed 2026-08-13
2025-06-30$28.00K
10-Q · filed 2026-08-13
$96.00K
derived: sum of 2 quarters · filed 2026-08-13
$222.00K
derived: sum of 3 quarters · filed 2026-08-13
$372.00K
derived: sum of 4 quarters · filed 2026-08-13
2025-03-31$68.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-26
$194.00K
derived: sum of 2 quarters · filed 2026-06-26
$344.00K
derived: sum of 3 quarters · filed 2026-06-26
$705.00K
10-K · filed 2026-06-26
2024-12-31$126.00K
10-Q · filed 2026-02-13
$276.00K
derived: sum of 2 quarters · filed 2026-02-13
$637.00K
10-Q · filed 2026-02-13
2024-09-30$150.00K
10-Q · filed 2025-11-10
$511.00K
10-Q · filed 2025-11-10
2024-06-30$361.00K
10-Q · filed 2025-08-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
Vivos Therapeutics, Inc. (VVOS)United States$0.003B-0.26
NEXGEL, INC. (NXGL)United States$0.002B
INVO Fertility, Inc. (IVF)United States$0.002B-0.71
Catheter Precision, Inc. (VTAK)United States$0.002B-0.23
Autonomix Medical, Inc. (AMIX)United States$0.004B
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
Tenon Medical, Inc. (TNON)United States$0.002B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Profusa, Inc. (PFSA)United States$0.002B
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B